Nicole Goodkind, politics reporter for Newsweek, discusses the controversial classified memo in light of the FBI director publicly announcing "grave concerns" with inaccuracies. We also dig into new updates in the Russia investigation.
We talk about the late-night tweet from Rep. Adam Schiff (D-CA) accusing Rep. Devin Nunes (R-CA) of making changes to the memo after the House Intel Committee vote and before sending it to the president for review.
We also discuss a New York Times report claiming that a former spokesperson of President Trump's will speak to special counsel Robert Mueller about a conversation with the White House Chief Communications Director. The conversation was allegedly about Trump Jr. and his meeting with Russian laywers.
The Congressional Budget Office expects the U.S. economy will grow at a 4.6% annual rate this year, but with employment not returning to pre-pandemic levels until 2024.
President Joe Biden is warning of a growing “cost of inaction” on his $1.9 trillion COVID relief plan.
From Wall Street to Silicon Valley, these are the top stories that moved markets and had investors, business leaders, and entrepreneurs talking this week on Cheddar.
Event organizers and other unconventional logistics experts are using their skills to help the nation vaccinate as many people against COVID-19 as possible.
The wave of small investors who have ballooned the price of GameStop stock in an unprecedented short squeeze are calling on each other to hold their positions even as trading platforms freeze additional sales.
Variants and Vaccines, Robinhood Under Fire & World's Biggest Rollercoaster
Consumers slowed their spending for a second straight month in a worrisome sign for an economy struggling under the weight of a still out-of-control pandemic.
The independent senator says multiple groups will benefit from the proceeds, including Meals on Wheels and Vermont community action agencies. He also says Getty Images will donate proceeds as part of a licensing agreement.
New York may have undercounted COVID-19 deaths among nursing home residents by thousands.
Employers weigh the pros and cons of potentially mandating workers get the COVID vaccine or incentivizing them to get the shots, a conundrum complicated by legal considerations.
